Martha Januar Wibawa, Sihite Teddy Arnold, Listina Desty
Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia.
Cardiol Res. 2021 Jun;12(3):177-185. doi: 10.14740/cr1247. Epub 2021 May 14.
In-hospital mortality of ST-elevation myocardial infarction (STEMI) patients varies between 1% and 19% in Asia. Global Registry of Acute Coronary Events (GRACE) score and Thrombolysis in Myocardial Infarction (TIMI) score are the most frequently used risk scores for predicting in-hospital mortality. These two scores have different accuracy depending on the risk profiles of each region. This study aimed to identify the difference in accuracy between GRACE and TIMI scores.
This was an observational cohort retrospective study on consecutive patients with STEMI admitted to Dr. Hasan Sadikin General Hospital Bandung between July 2018 and June 2019.
The risk scores were evaluated in 255 patients with STEMI, whose data were collected from medical records. Patients in this study were 58 ± 11 years old, more often male (78.8%) and have smoking (65.5%), dyslipidemia (61%), hypertension (56.5%) and diabetes mellitus (21.6 %) as their risk factors. Forty-five patients died in hospitalization (17%). The TIMI and GRACE scores revealed a significant graded increase in mortality with a rising score. There was a statistically significant difference in accuracy between the scores of 0.082 (95% confidence interval (CI): 0.040 - 0.125; P < 0.001) with the GRACE score (C statistics of 0.91; P < 0.001) having better accuracy compared to TIMI score (C statistics of 0.83; P < 0.001). This might be due to the fact that the GRACE scoring system has more detail and complete variables than the TIMI score.
There is a significant difference between the accuracy of GRACE and TIMI scores in predicting in-hospital mortality in STEMI patients. The accuracy of the GRACE score is better than the TIMI score for predicting in-hospital mortality in STEMI patients.
亚洲ST段抬高型心肌梗死(STEMI)患者的院内死亡率在1%至19%之间。全球急性冠状动脉事件注册研究(GRACE)评分和心肌梗死溶栓(TIMI)评分是预测院内死亡率最常用的风险评分。这两个评分的准确性因各地区的风险特征而异。本研究旨在确定GRACE评分和TIMI评分在准确性上的差异。
这是一项对2018年7月至2019年6月期间连续入住万隆哈桑·萨迪金综合医院的STEMI患者进行的观察性队列回顾性研究。
对255例STEMI患者的风险评分进行了评估,其数据来自病历。本研究中的患者年龄为58±11岁,男性更为常见(78.8%),有吸烟(65.5%)、血脂异常(61%)、高血压(56.5%)和糖尿病(21.6%)等风险因素。45例患者在住院期间死亡(17%)。TIMI和GRACE评分显示随着评分升高死亡率显著分级增加。评分准确性之间存在统计学显著差异,差异为0.082(95%置信区间(CI):0.040 - 0.125;P < 0.001),GRACE评分(C统计量为0.91;P < 0.001)的准确性优于TIMI评分(C统计量为0.83;P < 0.001)。这可能是因为GRACE评分系统比TIMI评分有更详细和完整的变量。
GRACE评分和TIMI评分在预测STEMI患者院内死亡率的准确性上存在显著差异。GRACE评分在预测STEMI患者院内死亡率方面的准确性优于TIMI评分。